"Since ours is an autonomous institute, we were waiting for the requisite approval from the ethics committee", Dr Sanjay Rai, Principal Investigator Covid-19 Vaccine trial at AIIMS, told The Sunday Express. The trials will be conducted by AIIMS Delhi from Monday on 100 healthy volunteers aged between 18 and 55. We are going to select healthy participants with no comorbidities and without a history of COVID-19. Human trial with Corona vaccine (COVAXIN) of Bharat Biotech started at PGI Rohtak today, Vij, who is also the Home and Science & Technology minister said.
Those between 18 and 55 years of age, with no heart, kidney, liver, or lung illness, and no uncontrolled diabetes or hypertension, will be eligible to participate in the study.
The department has launched a dedicated email ID and phone number for the project.
Apart from such optimistic expectations, allegations and rumors have spread far and wide that the Jenner Institute candidate vaccine may even provide "double-protection" against SARS-CoV-2, alongside various sources and media outlets claiming that the first phase of trials has been a huge success. "Few volunteers have already registered for the trial", he said.
An opposing comment was published by The Daily Telegraph, that had reported that an anonymous source had quoted that while "the combination of (antibodies and killer T-cells) will hopefully keep people safe", they had also stated that the vaccine development and production "have a long way to go".
Sushant Singh Rajput death: Filmmaker Aditya Chopra gives statement to Mumbai police
On Friday, the Mumbai Police had once again called in Sushant Singh Rajput's psychiatrist for questioning. The Police has been interrogating a lot of people who were connected to Sushant in some way or the other.
The University of Queensland is one of the front-runners in the global race to find a vaccine for COVID-19, working alongside Australian drug giant CSL.
Three volunteers were administered Covaxin. "Three subjects have enrolled for the trial and tolerated the vaccine very well". According to The Indian Express, AIIMS Patna and Post-Graduate Institute of Medical Sciences in Rohtak have already begun clinical trials of the vaccine.
Imperial said all participants were being closely monitored by a clinical team, who will record any potential adverse reactions and analyse participants' blood for the presence of neutralising antibodies against the virus.
The vaccine under trail is manufactured by Bharat Biotech International Ltd's named "covaxin" to fight against the novel coronavirus.
The Drug Controller General of India had granted permission to initiate Phase I and II human clinical trials after the company submitted results generated from pre-clinical studies, demonstrating safety and immune response.